Inventaire - أصدقاؤك ومجتمعاتك هم أفضل مكتبة لك

Hypoxia and angiogenesis in pancreatic cancer.

الكاتب

Ashley R Dennison

منشور في: ANZ Journal of Surgery

تاريخ النشر: 2006-09-01

Cites articles 79

Date

العنوان

الكاتبون

2005-04-12

Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]

Jürgen Debus, Markus Büchler
2005-01-01

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression

Alain Sauvanet, Adrian Harris
2005-09-01

Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer

Alok A Khorana, Steven A. Ahrendt
2005-07-15

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines

Daniel J. Hicklin
2005-11-01

Combination therapy with tumor-lysate pulsed dendritic cells and antiangiogenic drug TNP-470 for mouse pancreatic cancer
2005-03-01

A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.

Michael A. Quinn
2005-05-01

Selective inhibition of endothelin receptor A as an anti-angiogenic and anti-proliferative strategy for human pancreatic cancer
2005-01-01

Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice
2005-02-01

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
2005-06-01

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas

Alain Sauvanet, Adrian Harris
2004-10-01

Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer
2004-04-01

Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine

Isaiah J. Fidler
2004-12-15

Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis
2004-03-01

Prognostic value of VEGF in human pancreatic ductal adenocarcinoma
2004-04-01

Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential
2004-11-22

A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer

Kristian Pietras
2004-10-01

Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer

Debabrata Mukhopadhyay
2004-09-01

Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine

Romano Danesi, Generoso Bevilacqua, Guido Bocci
2004-01-01

Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression

Markus Büchler, Helmut Friess, Hans Peter Büchler, Howard A Reber, Oscar J Hines, Robert S Lavey
2003-01-22

Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer
2003-01-01

The medical management of pancreatic cancer: a review,The Medical Management of Pancreatic Cancer: A Review
2003-05-01

Adjuvant therapy in pancreatic cancer: historical and current perspectives

David Cunningham, Markus Büchler, Helmut Friess
2003-04-01

Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism
2003-03-01

Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour
2003-01-01

Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer

Nader G Abraham, Fuyuhiko Motoi
2003-10-01

Expression of carbonic anhydrase IX in human pancreatic cancer

Silvia Pastoreková
2003-02-01

Biology of angiogenesis in tumors of the gastrointestinal tract
2003-05-01

Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival

Kazuaki Chayama
2003-02-01

Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line

Debabrata Mukhopadhyay
2003-09-01

Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer

غريغ سيمينزا
2003-02-01

Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer
2003-11-01

Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis

Hirokazu Nagawa

مقالة - wd:Q36572752

أهلًا وسهلًا إلى آنڤانتير

مكتبة أصدقائك ومجتمعاتك

تعلم المزيد